Custom Antibody Market
English Public
Market Snapshot.
The custom antibodies market is estimated to reach approximately USD 112.544 million by 2033 from a market value of approximately USD 47.939 million in 2023, growing at a CAGR of 8.9% during the forecast period 2023-2033. The market is estimated to grow at a CAGR of 8.9% over the forecast period 2023-2033.
Market overview.
Increasing research activities (especially in the life sciences industry), growing industry-academia collaborations and expanding therapeutic antibody pipeline are the major growth drivers for this market. Rapid growth in developing countries in Asia Pacific and Latin America, increasing demand for personalised medicine and protein therapeutics is expected to provide significant growth opportunities for players in this market. However, the growing interest in alternative antibodies for proteomics research is part of the major challenges in the market due to high capital investment and the need for long-term antibody development.
Get a complete PDF sample copy of the report: https://www.sdki.jp/sample-request-61761
Custom antibodies market segments
The custom antibody market is segmented by service (antibody development, antibody production and purification, antibody fragmentation and labelling), by type (monoclonal, polyclonal and recombinant antibodies), by source (mouse, rabbit), by research area (cancer, immunology), and by end-user. These segments are further subdivided on the basis of various factors and include some additional information on the market, such as compound annual growth rate of each segment and sub-segment, market value and volume during the assessment period.
The antibody production and purification segment will show the highest growth rate during the forecast period.
On the basis of services, the custom antibody market is segmented into antibody development, antibody production and purification, and antibody fragmentation and labelling. The antibody production and purification segment is expected to witness the highest growth in the custom antibody services market during the forecast period. Growth in this segment is mainly driven by the need for high-quality antibodies for reproducibility of studies and generation of high-quality therapeutics.
The recombinant antibody segment is expected to grow at the highest CAGR during the forecast period.
On the basis of type, custom antibodies can be segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies and other custom antibodies. The recombinant antibody segment is projected to grow at the highest growth rate during the forecast period. Increasing development of recombinant antibodies will fuel the growth of this segment during the forecast period due to advantages such as batch-to-batch reproducibility, rapid production and data reproducibility within studies.
Read the full market research report here: https://www.sdki.jp/reports/custom-antibody-market/61761
Competitive landscape
Key players in the custom antibodies market include Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Merck Group (Germany), Abcam plc (English), Cell Signaling Technology (USA), Agilent Technologies, Inc (USA), GenScript (USA), BioLegend, Inc (USA), Rockland Immunochemicals (USA), ProMab Biotechnologies (USA), Innovagen AB (Sweden), ProteoGenix (USA) and others. Also present. The study includes detailed competitive analysis, company profiles, recent developments and key market strategies for these key players in the custom antibodies market.
The custom antibodies market is estimated to reach approximately USD 112.544 million by 2033 from a market value of approximately USD 47.939 million in 2023, growing at a CAGR of 8.9% during the forecast period 2023-2033. The market is estimated to grow at a CAGR of 8.9% over the forecast period 2023-2033.
Market overview.
Increasing research activities (especially in the life sciences industry), growing industry-academia collaborations and expanding therapeutic antibody pipeline are the major growth drivers for this market. Rapid growth in developing countries in Asia Pacific and Latin America, increasing demand for personalised medicine and protein therapeutics is expected to provide significant growth opportunities for players in this market. However, the growing interest in alternative antibodies for proteomics research is part of the major challenges in the market due to high capital investment and the need for long-term antibody development.
Get a complete PDF sample copy of the report: https://www.sdki.jp/sample-request-61761
Custom antibodies market segments
The custom antibody market is segmented by service (antibody development, antibody production and purification, antibody fragmentation and labelling), by type (monoclonal, polyclonal and recombinant antibodies), by source (mouse, rabbit), by research area (cancer, immunology), and by end-user. These segments are further subdivided on the basis of various factors and include some additional information on the market, such as compound annual growth rate of each segment and sub-segment, market value and volume during the assessment period.
The antibody production and purification segment will show the highest growth rate during the forecast period.
On the basis of services, the custom antibody market is segmented into antibody development, antibody production and purification, and antibody fragmentation and labelling. The antibody production and purification segment is expected to witness the highest growth in the custom antibody services market during the forecast period. Growth in this segment is mainly driven by the need for high-quality antibodies for reproducibility of studies and generation of high-quality therapeutics.
The recombinant antibody segment is expected to grow at the highest CAGR during the forecast period.
On the basis of type, custom antibodies can be segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies and other custom antibodies. The recombinant antibody segment is projected to grow at the highest growth rate during the forecast period. Increasing development of recombinant antibodies will fuel the growth of this segment during the forecast period due to advantages such as batch-to-batch reproducibility, rapid production and data reproducibility within studies.
Read the full market research report here: https://www.sdki.jp/reports/custom-antibody-market/61761
Competitive landscape
Key players in the custom antibodies market include Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Merck Group (Germany), Abcam plc (English), Cell Signaling Technology (USA), Agilent Technologies, Inc (USA), GenScript (USA), BioLegend, Inc (USA), Rockland Immunochemicals (USA), ProMab Biotechnologies (USA), Innovagen AB (Sweden), ProteoGenix (USA) and others. Also present. The study includes detailed competitive analysis, company profiles, recent developments and key market strategies for these key players in the custom antibodies market.
by akiariku
Vocabulary List
- 0
